Annual prevalence and treatment estimates of nontuberculous mycobacterial pulmonary disease in Europe: A NTM-NET collaborative study

D. Wagner, J. van Ingen, J. Adjemian, C. Lange, D. R. Prevots, D. Griffith, J. Gallagher, R. Gupta, C. Haworth (Freiburg, Borstel, Germany; Nijmegen, Netherlands; Bethesda, Tyler, Spartanburg, Monmouth Junction, United States Of America; Cambridge, United Kingdom)

Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer
Session: The epidemiology of respiratory infections and lung cancer
Session type: Thematic Poster Session
Number: 1067
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Wagner, J. van Ingen, J. Adjemian, C. Lange, D. R. Prevots, D. Griffith, J. Gallagher, R. Gupta, C. Haworth (Freiburg, Borstel, Germany; Nijmegen, Netherlands; Bethesda, Tyler, Spartanburg, Monmouth Junction, United States Of America; Cambridge, United Kingdom). Annual prevalence and treatment estimates of nontuberculous mycobacterial pulmonary disease in Europe: A NTM-NET collaborative study. Eur Respir J 2014; 44: Suppl. 58, 1067

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comparison of treatment practices for nontuberculous mycobacterial pulmonary disease in Japan, Europe, and United States
Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer
Year: 2014

Epidemiology and clinical features of nontuberculous mycobacterial lung disease in a subtropical region in Japan: Analysis with a 7-year data in two major hospitals
Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Year: 2016


Analysis of nontuberculous mycobacteriosis deaths in official statistics, 1970-2010, and a recent clinical cohort study for the estimation of prevalence rate in Japan
Source: Annual Congress 2013 –Interesting research questions
Year: 2013


Nontuberculous mycobacteria in the Danish population, incidence rate and clinical importance during 24 years
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook
Year: 2015

Stricter microbiological criteria are useful surrogate in estimating the prevalence of nontuberculous mycobacterial pulmonary disease in Croatia
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015


Are epidemiological statistics on extrapulmonary tuberculosis correct?
Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease
Year: 2016


Active detection of tuberculosis in homeless populations may reduce the incidence of tuberculosis in the general population
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014


Non tuberculous mycobacteria (NTM) contamination in a hospital water supply network: Association with pulmonary infection in respiratory wards
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015

Population based survey on the NTM pulmonary disease treatment in Japan
Source: International Congress 2018 – The global impact of bronchiectasis and nontuberculous mycobacteria (NTM)
Year: 2018


Latent tuberculosis infection and the risk of cancer: A nationwide population-based study
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015

Differences in tuberculosis disease among immigrant and native populations
Source: Annual Congress 2013 –Tuberculosis: clinical epidemiology and public health
Year: 2013


Increased incidence of TB disease within the health-care workers in an intermediate TB burden country
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014

Treatment effectiveness of TB patients from different groups of population in Moscow
Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis
Year: 2016


Clinical importance of pulmonary nontuberculous mycobacteria isolated among HIV-positive individuals in Ghana
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015

Clinical outcome of multiple nontuberculous mycobacteria infection among people with bronchiectasis in Taiwan: a cohort study
Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria
Year: 2020


The change of tuberculosis features through decades in immune-competent patients
Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer
Year: 2014


Geographic origin and other determinants of site of tuberculosis disease in European countries
Source: International Congress 2014 – Tuberculosis epidemiology: novel features
Year: 2014

Heterogeneity in bronchiectasis service provision in Europe: Baseline data from the European bronchiectasis registry (EMBARC)
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook
Year: 2015

Latent tuberculosis infection prevalence and risk of developing active TB among patients eligible for starting anti-TNFα therapy
Source: International Congress 2015 – Screening strategies in TB
Year: 2015

Screening immigrants to Ireland from countries with a high prevalence of tuberculosis would be clinically beneficial and cost effective
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Year: 2013